Article
Treatment of cerebral adrenoleukodystrophy: allogeneic transplantation and lentiviral gene therapy
2 Sept 2022
Abstract excerpt
INTRODUCTION: gene. By adulthood, approximately 40% of the patients develop cerebral ALD, a severe, neuroinflammatory condition that is generally progressive and fatal without intervention. AREAS COVERED: Historically, only allogeneic hematopoietic stem cell transplantation (HSCT) has been shown to halt progression of cerebral ALD, with superior outcomes obtained when HSCT is performed early in the disease...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
